ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025
Comparison Between Intranasal Insulin Films Alone and Combined Intranasal Insulin Plus Steroid Films for Post Viral Olfactory Dysfunction.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Efficacy of Intranasal Insulin in the Treatment of Post-Viral Persistent Olfactory Dysfunction: A Systematic Review.Clinical and experimental otorhinolaryngology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olfactory dysfunction has emerged as a prominent symptom of post viral (COVID 19) rhinitis, persisting in a subset of patients even after recovery. Insulin (IN)receptors are found in the olfactory mucosa, and it has been noticed that IN treatment promotes olfactory sensory neuron regeneration, so it is included in the list of possible methods for treating olfactory impairment. To compare the effect of intranasal insulin films on improving post viral olfactory dysfunction in one group of patients and improving the prepared formulation by addition of another active ingredient (Budesonide) and study the percentage of recovery from this combination on another group of patients. The study included 250 patients of both sexes with post viral (COVID 19) olfactory dysfunction and divided into 2 groups Group A (n = 125 patients) received 100 IU of insulin combined with 10 mg budesonide and Group B (125 patients) received 100 IU of insulin only. Olfactory improvement in both groups after intranasal insulin fast dissolving film application were observed, olfactory scores were recorded in the group which received combined films containing Budesonide added to the insulin, signifying the important role of Budesonide together with insulin in improving Post viral olfactory dysfunction. Intranasal insulin therapy is a viable technique to treating post viral olfactory impairment since it improves both olfactory threshold and discrimination. Furthermore, combining Budesonide with insulin in the unique fast dissolving intranasal films produced significantly better results (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.